288 related articles for article (PubMed ID: 30693797)
1. A Gene Therapy Approach to Improve Copper Metabolism and Prevent Liver Damage in a Mouse Model of Wilson Disease.
Greig JA; Nordin JML; Smith MK; Ashley SN; Draper C; Zhu Y; Bell P; Buza EL; Wilson JM
Hum Gene Ther Clin Dev; 2019 Mar; 30(1):29-39. PubMed ID: 30693797
[TBL] [Abstract][Full Text] [Related]
2. Long-Term Correction of Copper Metabolism in Wilson's Disease Mice with AAV8 Vector Delivering Truncated ATP7B.
Leng Y; Li P; Zhou L; Xiao L; Liu Y; Zheng Z; Qin F; Hao Q; Xu H; Yao S; Dong B
Hum Gene Ther; 2019 Dec; 30(12):1494-1504. PubMed ID: 31668086
[TBL] [Abstract][Full Text] [Related]
3. Liver Expression of a MiniATP7B Gene Results in Long-Term Restoration of Copper Homeostasis in a Wilson Disease Model in Mice.
Murillo O; Moreno D; Gazquez C; Barberia M; Cenzano I; Navarro I; Uriarte I; Sebastian V; Arruebo M; Ferrer V; Bénichou B; Combal JP; Prieto J; Hernandez-Alcoceba R; Gonzalez Aseguinolaza G
Hepatology; 2019 Jul; 70(1):108-126. PubMed ID: 30706949
[TBL] [Abstract][Full Text] [Related]
4. Long-term metabolic correction of Wilson's disease in a murine model by gene therapy.
Murillo O; Luqui DM; Gazquez C; Martinez-Espartosa D; Navarro-Blasco I; Monreal JI; Guembe L; Moreno-Cermeño A; Corrales FJ; Prieto J; Hernandez-Alcoceba R; Gonzalez-Aseguinolaza G
J Hepatol; 2016 Feb; 64(2):419-426. PubMed ID: 26409215
[TBL] [Abstract][Full Text] [Related]
5. Animal models of Wilson disease.
Medici V; Huster D
Handb Clin Neurol; 2017; 142():57-70. PubMed ID: 28433110
[TBL] [Abstract][Full Text] [Related]
6. Wilson disease and related copper disorders.
Lorincz MT
Handb Clin Neurol; 2018; 147():279-292. PubMed ID: 29325617
[TBL] [Abstract][Full Text] [Related]
7. Early gestational gene transfer with targeted ATP7B expression in the liver improves phenotype in a murine model of Wilson's disease.
Roybal JL; Endo M; Radu A; Gray L; Todorow CA; Zoltick PW; Lutsenko S; Flake AW
Gene Ther; 2012 Nov; 19(11):1085-94. PubMed ID: 22158007
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic changes of the thioredoxin system in the tx-j mouse model and in patients with Wilson disease.
Mordaunt CE; Shibata NM; Kieffer DA; Czlonkowska A; Litwin T; Weiss KH; Gotthardt DN; Olson K; Wei D; Cooper S; Wan YY; Ali MR; LaSalle JM; Medici V
Hum Mol Genet; 2018 Nov; 27(22):3854-3869. PubMed ID: 30010856
[TBL] [Abstract][Full Text] [Related]
9. [Research progress in gene therapy for Wilson's disease].
Tang S; Bai L; Zheng SJ
Zhonghua Gan Zang Bing Za Zhi; 2021 Jan; 29(1):21-24. PubMed ID: 33541020
[TBL] [Abstract][Full Text] [Related]
10. [Wilson disease: an update].
Seo JK
Korean J Hepatol; 2006 Sep; 12(3):333-63. PubMed ID: 16998287
[TBL] [Abstract][Full Text] [Related]
11. Wilson's disease: Prospective developments towards new therapies.
Ranucci G; Polishchuck R; Iorio R
World J Gastroenterol; 2017 Aug; 23(30):5451-5456. PubMed ID: 28852304
[TBL] [Abstract][Full Text] [Related]
12. A novel gross deletion and breakpoint junction sequence analysis of ATP7B in a Chinese family with Wilson disease using next‑generation sequencing and Sanger sequencing.
Liu WL; Li F; Liu L; Chen W; He ZX; Gu H; Ai R
Mol Med Rep; 2020 Jan; 21(1):517-523. PubMed ID: 31746411
[TBL] [Abstract][Full Text] [Related]
13. Activation of Autophagy, Observed in Liver Tissues From Patients With Wilson Disease and From ATP7B-Deficient Animals, Protects Hepatocytes From Copper-Induced Apoptosis.
Polishchuk EV; Merolla A; Lichtmannegger J; Romano A; Indrieri A; Ilyechova EY; Concilli M; De Cegli R; Crispino R; Mariniello M; Petruzzelli R; Ranucci G; Iorio R; Pietrocola F; Einer C; Borchard S; Zibert A; Schmidt HH; Di Schiavi E; Puchkova LV; Franco B; Kroemer G; Zischka H; Polishchuk RS
Gastroenterology; 2019 Mar; 156(4):1173-1189.e5. PubMed ID: 30452922
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive and comparative exploration of the Atp7b
Lacombe M; Jaquinod M; Belmudes L; Couté Y; Ramus C; Combes F; Burger T; Mintz E; Barthelon J; Leroy V; Poujois A; Lachaux A; Woimant F; Brun V
Metallomics; 2020 Feb; 12(2):249-258. PubMed ID: 31815268
[TBL] [Abstract][Full Text] [Related]
15. [Management of hepatolenticular degeneration during pregnancy].
Bai J; Zheng SJ; Duan ZP
Zhonghua Gan Zang Bing Za Zhi; 2022 Jan; 30(1):107-109. PubMed ID: 35152680
[TBL] [Abstract][Full Text] [Related]
16. ATP7B gene therapy of autologous reprogrammed hepatocytes alleviates copper accumulation in a mouse model of Wilson's disease.
Cai H; Cheng X; Wang XP
Hepatology; 2022 Oct; 76(4):1046-1057. PubMed ID: 35340061
[TBL] [Abstract][Full Text] [Related]
17. Functional iron deficiency in toxic milk mutant mice (tx-J) despite high hepatic ferroportin: a critical role of decreased GPI-ceruloplasmin expression in liver macrophages.
Jończy A; Lipiński P; Ogórek M; Starzyński RR; Krzysztofik D; Bednarz A; Krzeptowski W; Szudzik M; Haberkiewicz O; Miłoń A; Grzmil P; Lenartowicz M
Metallomics; 2019 Jun; 11(6):1079-1092. PubMed ID: 31011744
[TBL] [Abstract][Full Text] [Related]
18. Structural and metabolic changes in Atp7b-/- mouse liver and potential for new interventions in Wilson's disease.
Huster D
Ann N Y Acad Sci; 2014 May; 1315():37-44. PubMed ID: 24697742
[TBL] [Abstract][Full Text] [Related]
19. Activation of liver X receptor/retinoid X receptor pathway ameliorates liver disease in Atp7B(-/-) (Wilson disease) mice.
Hamilton JP; Koganti L; Muchenditsi A; Pendyala VS; Huso D; Hankin J; Murphy RC; Huster D; Merle U; Mangels C; Yang N; Potter JJ; Mezey E; Lutsenko S
Hepatology; 2016 Jun; 63(6):1828-41. PubMed ID: 26679751
[TBL] [Abstract][Full Text] [Related]
20. Toxic milk mice models of Wilson's disease.
Hadrian K; Przybyłkowski A
Mol Biol Rep; 2021 Feb; 48(2):1903-1914. PubMed ID: 33590415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
